Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
A recent preemption decision out of the Southern District of New York offers encouraging news for medical device ...
11h
FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
FDA's new guidance clarifies promotional practices for biosimilars, ensuring accurate marketing and preventing misleading ...
Treatment with neflamapimod slowed clinical worsening and led to reduced disease-related plasma biomarkers in individuals with dementia with Lewy bodies, according to a speaker at CTAD. “Dementia with ...
The cookies were sold between November 15 and December 9 at all Lunds & Byerlys stores in the Twin Cities and St. Cloud ...
A new study shows that some widely used BPA replacements can kill cells and disrupt key functions, prompting scientists to ...
Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs ...
The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
Federal, state, and private actions are accelerating across color additives, labeling and packaging, heavy metals, ultraprocessed foods, and ...
The vast majority of what we do would be eliminated if people fix their diet,” says cardiologist Kim Allan Williams Sr.
Democratic senators have introduced a new bill to create a federal regulatory framework for hemp-derived cannabinoids and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback